🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tetsuji Takayama

Tokushima University

ORCID: 0000-0002-0175-1573

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma”.

LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma

Carcinogenesis(2021)10.1093/carcin/bgab011

N/A

0DataRank · unranked

79 citations

Naoki Takahashi, Tetsuji Takayama, Ajay Goel, Yasuyuki Okada

Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma

European Journal of Cancer(2021)10.1016/j.ejca.2020.12.031

N/A

0DataRank · unranked

14 citations

Satoshi Nishiwada, Kensuke Yamamura, Masayuki Sho, Hideo Baba, Tetsuji Takayama +2 more

A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study

Molecular Cancer(2022)10.1186/s12943-022-01507-x

N/A

0DataRank · unranked

87 citations

Zhongxu Zhu, Aiping Luo, Shusuke Toden, Xuantong Zhou, Daisuke Izumi +13 more

Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma

Biomedicines(2023)10.3390/biomedicines11010119

N/A

0DataRank · unranked

11 citations

Caiming Xu, Silvia Pascual-Sabater, Masanori Tokunaga, Tetsuji Takayama, Haiyong Han +4 more